Document Detail


Ulcerative colitis: current pharmacotherapy and future directions.
MedLine Citation:
PMID:  24897949     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Introduction: Ulcerative colitis (UC) is a chronic relapsing disease, characterised by alternating of acute and remission phases. Although the aetiology is unknown, in recent years, there has progressively been greater knowledge of the various pathogenetic mechanisms underlying the disease itself. Thus, from therapy based on generically anti-inflammatory or immunosuppressive agents, treatment is gradually moving towards drugs that selectively block specific inflammatory mediators, such as TNF-α. Areas covered: This review provides the most significant data about the therapeutic role of different drugs currently available for the treatment of UC. In addition, the critical therapeutic areas on which research could focus in the near future are discussed. Expert opinion: UC is a disease affecting young patients, whose quality of life may be strongly compromised by the progression of disease. Over time, the disease may lead to an impairment of the normal anatomy and physiology of the colon, and the cumulative incidence of dysplasia and colorectal cancer increases with the time. Thus, the main aims of the near future should be both a better definition of patients at risk for a poor clinical course and progression of disease, and the development of a much more aggressive treatment for patients with a poor prognosis.
Authors:
Cristina Bezzio; Federica Furfaro; Roberto de Franchis; Giovanni Maconi; Anil Kumar Asthana; Sandro Ardizzone
Related Documents :
24369419 - Spondyloarthritis: from unifying concepts to improved treatment.
23793209 - Neurofibromatosis: chronological history and current issues.
21323189 - Bilateral fluorescein angiographic findings in unilateral coats' disease.
21189219 - The development of anti-inflammatory drugs for infectious diseases.
23295699 - The risks and benefits of early immunosuppression and biological therapy.
23365789 - Emerging molecular targets for brain repair after stroke.
24154119 - Longitudinal evolution of lymphocytic interstitial pneumonia (lip) in an hiv-positive man.
24052039 - Differential diagnosis of glomerular disease: a systematic and inclusive approach.
9818249 - Disorders of the pancreas in children.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-6-5
Journal Detail:
Title:  Expert opinion on pharmacotherapy     Volume:  -     ISSN:  1744-7666     ISO Abbreviation:  Expert Opin Pharmacother     Publication Date:  2014 Jun 
Date Detail:
Created Date:  2014-6-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897346     Medline TA:  Expert Opin Pharmacother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-12     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Scabies and bedbugs in hospital outbreaks.
Next Document:  Mechanics and spiral formation in the rat cornea.